ConductScience.org, home

Paper41385341

Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.

Meyer EH and 25 others. Blood, 2026. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial. Papers, record 41385341. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41385341

Download JSON
Disease
myelodysplastic syndrome421 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Orca-T vs allogeneic hematopoietic stem cell transplantation (Precision-T): a multicenter, randomized phase 3 trial.
PubMed
Journal
Blood
PubMed
Year
2026
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
6.72, provisional
iCite
Revised in PubMed
2026-10-28
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meyer EHEverett H
2Salhotra AAmandeep
3Gandhi APArpita P
4Pantin JJeremy
5Patel SSSagar Shttps://orcid.org/0000-0001-9949-3615
6Hoeg RTRasmus T
7Gomez-Arteaga AAlexandrahttps://orcid.org/0000-0003-0897-3790
8Faramand RRawanhttps://orcid.org/0000-0001-7750-781X
9Tamari RRoni
10Waller EKEdmund Khttps://orcid.org/0000-0003-0816-6729
11Kosuri SSatyajit
12Jimenez Jimenez AMAntonio Mhttps://orcid.org/0000-0003-2817-6836
13Holter-Chakrabarty JJenniferhttps://orcid.org/0000-0003-1425-7002
14Dholaria BBhagirathbhaihttps://orcid.org/0000-0003-2371-3655
15Chen YBYi-Binhttps://orcid.org/0000-0002-9554-1058
16Hamilton BKBetty Khttps://orcid.org/0000-0003-1252-6539
17Magenau JJohn
18Eghtedar AAlireza
19Murray JMJoshua M
20Pavlova AAnnahttps://orcid.org/0000-0002-5533-5700

Source PubMed

See all 26 authorsDownload CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem Cell TransplantationMajor topic
Graft vs Host DiseaseMajor topic
Myelodysplastic SyndromesMajor topic
LeukemiaMajor topic
Humans
Male
Adult
Middle Aged
Female
Transplantation, Homologous
Aged
Methotrexate
Young Adult
Transplantation Conditioning
Adolescent
Tacrolimus

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMed

Source NIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05316701Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesResultsYesClinicalTrials.gov
NCT07346105Orca-T Expanded Access Program Study for Patients With Advanced Hematologic MalignanciesBackgroundClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in41817555Graft manipulation and GVHD: what goes around comes around.https://conductscience.org/library/papers/41817555

Source PubMed

Download CSV of comments and corrections

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129171820Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.N Engl J Med2017https://conductscience.org/library/papers/29171820PubMed
237330731Early immune reconstitution as predictor for outcomes after allogeneic hematopoietic cell transplant; a tri-institutional analysis.Cytotherapy2023https://conductscience.org/library/papers/37330731PubMed
331023346
Fludarabine-treosulfan compared to thiotepa-busulfan-fludarabine or FLAMSA as conditioning regimen for patients with primary refractory or relapsed acute myeloid leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT).
J Hematol Oncol2019https://conductscience.org/library/papers/31023346PubMed
426563133Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.Blood2016https://conductscience.org/library/papers/26563133PubMed
517095616In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation.Blood2007https://conductscience.org/library/papers/17095616PubMed
626735993Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.N Engl J Med2016https://conductscience.org/library/papers/26735993PubMed
729423053Thiotepa-busulfan-fludarabine compared to busulfan-fludarabine for sibling and unrelated donor transplant in acute myeloid leukemia in first remission.Oncotarget2018https://conductscience.org/library/papers/29423053PubMed
831092732Transplantation of donor grafts with defined ratio of conventional and regulatory T cells in HLA-matched recipients.JCI Insight2019https://conductscience.org/library/papers/31092732PubMed
915994282Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.Blood2005https://conductscience.org/library/papers/15994282PubMed
1033646302Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia.Blood Adv2021https://conductscience.org/library/papers/33646302PubMed
1142628650Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients.Transplant Cell Ther2026https://conductscience.org/library/papers/42628650PubMed
1237342922Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.N Engl J Med2023https://conductscience.org/library/papers/37342922PubMed
1326386318International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.Biol Blood Marrow Transplant2016https://conductscience.org/library/papers/26386318PubMed
1434855460Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies.J Clin Oncol2022https://conductscience.org/library/papers/34855460PubMed
1525994967Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.J Immunol2015https://conductscience.org/library/papers/25994967PubMed
1629040031
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.
J Clin Oncol2017https://conductscience.org/library/papers/29040031PubMed
1712925844CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.Nat Med2003https://conductscience.org/library/papers/12925844PubMed
1828395942Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.Cytotherapy2017https://conductscience.org/library/papers/28395942PubMed
1924415540Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHD.Blood2014https://conductscience.org/library/papers/24415540PubMed
2040398621Current Activity Trends and Outcomes in Hematopoietic Cell Transplantation and Cellular Therapy - A Report from the CIBMTR.Transplant Cell Ther2025https://conductscience.org/library/papers/40398621PubMed

See all 30 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42920839Regulatory T cell heterogeneity: who they are, where they come from, and where they go.Front Immunol2026https://conductscience.org/library/papers/42920839PubMed
42753097Orca-T: First Approval.Mol Diagn Ther2026https://conductscience.org/library/papers/42753097PubMed
42739525Indications for Autologous and Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: State of the Art.J Clin Med2026https://conductscience.org/library/papers/42739525PubMed
42344227CD8 regulatory T cell therapy in transplantation: a new path to clinical success?Transpl Int2026https://conductscience.org/library/papers/42344227PubMed
42060316Boosting "Treg-ulation": a good way to treat chronic GVHD?Blood Adv2026https://conductscience.org/library/papers/42060316PubMed
41758930Regulatory-like FOXP3+Helios+CD4+ T conventional cells correlate with T-cell activation after Orca-T immunotherapy.Blood2026https://conductscience.org/library/papers/41758930PubMed

Download CSV of cited by

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
TACROLIMUSCHEMBL3989887Results1https://conductscience.org/library/drugs/CHEMBL3989887

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41385341

GET https://conductscience.org/api/papers/v1/41385341/authors?page=2